Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) participated in the recent Health Care Innovation event, sponsored by Globe and Mail. The event featured leaders from an array of sectors in the space, including Avricore Health CEO Hector Bremner. The premier event included health sector leaders, academics, governmental agency representatives, physicians and patient advocates. Avricore is strengthening its position in the healthcare sector by offering its proprietary HealthTab(TM) platform, a turnkey point-of-care testing solution that brings together best-in-class, point-of-care technologies with a secure, cloud-based platform. According to the release, the HealthTab system produces lab-accurate results on the spot with real-time data, reducing costs and waiting times — all from only a finger prick. With HealthTab, pharmacists can be more involved in primary care and patients can have more control of their health. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease as well as bacterial and viral tests, such as strep and COVID-19. “With about 40% of patients in Canada saying it’s difficult to access a diagnostics test and nine million expressing difficulty in getting access to care, it’s clear that the time is now to support more services in community pharmacy,” says Avricore Health CEO Hector Bremner in the press release. “HealthTab is already playing a significant role in supporting better services in pharmacy and we’re going to continue to advocate for patients, and providers, so better outcomes for all are achieved.”
To view the full press release, visit https://ibn.fm/isjTM
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab, a wholly owned subsidiary, the company’s mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid-testing devices in community pharmacies. For more information about the company, please visit www.AvricoreHealth.com
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.